首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Comparison of Physician-Modified Fenestrated/Branched Stent-Grafts and Hybrid Visceral Debranching Plus Stent-Graft Placement for Complex Thoracoabdominal Aortic Aneurysm Repair
【24h】

Comparison of Physician-Modified Fenestrated/Branched Stent-Grafts and Hybrid Visceral Debranching Plus Stent-Graft Placement for Complex Thoracoabdominal Aortic Aneurysm Repair

机译:医师改性的未封入/分支支架和混合内脏脱枝加上复合胸腔腹主动脉瘤修复的支架置置的比较

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose:To evaluate the immediate postoperative and midterm outcomes of complex thoracoabdominal aortic aneurysm (TAAA) treatment with fenestrated/branched physician-modified endovascular grafts (PMEGs) or open debranching of the visceral aorta with bypass graft revascularization plus endovascular aneurysm exclusion (hybrid repair).Materials and Methods:A retrospective analysis was conducted of 88 patients (mean age 70.0 +/- 10.6 years; 73 men) with complex TAAAs who underwent treatment with PMEGs (60, 68%) or a hybrid technique (28, 32%) between 2016 and 2019. The mean aneurysm diameter was 64.5 +/- 11.7 mm, and 37 patients (42%) were symptomatic. The Zenith TX2 and Ankura were the main stent-grafts used in the PMEG group. The hybrid technique involved visceral debranching with extra-anatomical bypass graft revascularization and subsequent stent-graft deployment (1- or 2-stage procedure).Results:In the PMEG group, 35 patients received modified stent-grafts with 4 fenestrations, 8 patients had 4 branches per device, and 17 patients had combinations (50 fenestrations and 18 branches) that successfully revascularized 228 of the 240 targets (95%). In the 28 hybrid cases, all 110 target vessels were successfully revascularized with bypass grafts. The overall 30-day mortality was 3.4% (2 PMEG and 1 hybrid), and the early rate of target vessel stenosis/occlusion was 3.3% (5 in PMEG group and 6 in the hybrid repair group). The 30-day morbidity was mainly attributed to pulmonary complications (15%), lower limb ischemia (8%), or spinal cord ischemia with paraplegia (6%). Eleven patients (13%) had deteriorated renal function with a >30% decrease in the glomerular filtration rate. The mean follow-up was 22.3 +/- 4.9 months, and mortality was 4.5% (3.3% in the PMEG group vs 7.1% in the hybrid repair group).Conclusion:PMEGs and hybrid techniques seem to be feasible treatment options for aortic aneurysms necessitating visceral vessel revascularization. PMEGs may have a lower morbidity than the hybrid technique, which nonetheless remains an important option available for complex aortic aneurysms.
机译:目的:评估复杂胸腹主动脉瘤(TAAA)采用开窗/分支医师改良血管内移植物(PMEGs)或内脏主动脉开放性去支术(旁路移植物血运重建+血管内动脉瘤剔除术(混合修复))治疗的近期和中期结果。材料和方法:对88例复杂TAAAs患者(平均年龄70.0+/-10.6岁;73名男性)进行回顾性分析,他们在2016年至2019年间接受了PMEGs(60,68%)或混合技术(28,32%)治疗。平均动脉瘤直径为64.5+/-11.7mm,37名患者(42%)有症状。PMEG组主要使用Zenith TX2和Ankura支架。混合技术包括内脏去支、解剖外旁路移植血管重建和随后的支架移植部署(1或2阶段程序)。结果:在PMEG组,35名患者接受了带有4个开窗的改良支架移植物,8名患者每个装置有4个分支,17名患者采用了组合(50个开窗和18个分支),成功地重建了240个靶点中的228个(95%)。在28例杂交病例中,所有110条靶血管均通过旁路移植成功重建。总的30天死亡率为3.4%(2例PMEG和1例hybrid),靶血管狭窄/闭塞的早期发生率为3.3%(PMEG组5例,hybrid修复组6例)。30天的发病率主要归因于肺部并发症(15%)、下肢缺血(8%)或脊髓缺血伴截瘫(6%)。11名患者(13%)肾功能恶化,肾小球滤过率下降>30%。平均随访时间为22.3+/-4.9个月,死亡率为4.5%(PMEG组为3.3%,混合修复组为7.1%)。结论:对于需要内脏血管血运重建的主动脉瘤,PMEGs和混合技术似乎是可行的治疗选择。PMEGs的发病率可能比混合技术低,尽管如此,混合技术仍然是治疗复杂主动脉瘤的重要选择。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号